|1 Table of Contents 3
|1.1 List of Tables 5
|1.2 List of Figures 5
2 Introduction 7
2.1 What Is This Report About? 7
2.2 Drug Delivery Devices Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8
3 Drug Delivery Devices Market, South Korea 10
3.1 Drug Delivery Devices Market, South Korea, Revenue ($m), 2018-2033 10
3.2 Drug Delivery Devices Market, South Korea, Revenue Mix ($m), 2023 11
3.3 Drug Delivery Devices Market, South Korea, Category Contribution by Revenue ($m), 2023 12
3.4 Drug Delivery Devices Market, South Korea, Revenue ($m), 2018-2033 13
3.5 Drug Delivery Devices Market, South Korea, Volume (Units), 2018-2033 15
3.6 Drug Delivery Devices Market, South Korea, Volume (Units), 2018-2033 16
3.7 Drug Delivery Devices Market, South Korea, Company Share by Revenue ($m), 2023 18
4 Central Venous Catheters Market, South Korea 20
4.1 Central Venous Catheters Market, South Korea, Revenue Mix ($m), 2023 20
4.2 Central Venous Catheters Market, South Korea, Segment Contribution (%), 2023 21
4.3 Central Venous Catheters Market, South Korea, Revenue ($m), 2018-2033 22
4.4 Central Venous Catheters Market, South Korea, Volume (Units), 2018-2033 24
4.5 Central Venous Catheters Market, South Korea, Average Price ($) , 2018-2033 26
4.6 Central Venous Catheters Market, South Korea, Distribution Share by Revenue ($m), 2023 27
4.7 Central Venous Catheters Market, South Korea, Company Share by Revenue ($m), 2023 28
5 Implantable Ports Market, South Korea 30
5.1 Implantable Ports Market, South Korea, Revenue Mix ($m), 2023 30
5.2 Implantable Ports Market, South Korea, Segment Contribution (%), 2023 31
5.3 Implantable Ports Market, South Korea, Revenue ($m), 2018-2033 32
5.4 Implantable Ports Market, South Korea, Volume (Units), 2018-2033 34
5.5 Implantable Ports Market, South Korea, Average Price ($) , 2018-2033 36
5.6 Implantable Ports Market, South Korea, Distribution Share by Revenue ($m), 2023 37
5.7 Implantable Ports Market, South Korea, Company Share by Revenue ($m), 2023 38
6 Infusion Systems Market, South Korea 39
6.1 Infusion Systems Market, South Korea, Revenue Mix ($m), 2023 39
6.2 Infusion Systems Market, South Korea, Segment Contribution (%), 2023 40
6.3 Infusion Systems Market, South Korea, Revenue ($m), 2018-2033 41
6.3.1 Infusion Pump Disposables Market, South Korea, Revenue ($m), by Segment, 2018-2033 43
6.3.2 Infusion Pumps Market, South Korea, Revenue ($m), by Segment, 2018-2033 45
6.4 Infusion Systems Market, South Korea, Volume (Units), 2018-2033 47
6.4.1 Infusion Pump Disposables Market, South Korea, Volume (Units), by Segment, 2018-2033 49
6.4.2 Infusion Pumps Market, South Korea, Volume (Units), by Segment, 2018-2033 51
6.5 Infusion Systems Market, South Korea, Average Price ($) , 2018-2033 53
6.6 Infusion Systems Market, South Korea, Distribution Share by Revenue ($m), 2023 54
6.7 Infusion Systems Market, South Korea, Company Share by Revenue ($m), 2023 55
7 Overview of Key Companies in South Korea, Drug Delivery Devices Market 56
7.1 Becton Dickinson and Co 56
7.1.1 Company Overview 56
7.2 B. Braun Melsungen AG 56
7.2.1 Company Overview 56
7.3 Teleflex Inc 56
7.3.1 Company Overview 56
7.4 Edwards Lifesciences Corp 56
7.4.1 Company Overview 56
7.5 Baxter International Inc 57
7.5.1 Company Overview 57
7.6 Vygon SA 57
7.6.1 Company Overview 57
7.7 ICU Medical Inc 57
7.7.1 Company Overview 57
8 Drug Delivery Devices Market Pipeline Products 58
9 Financial Deals Landscape 66
9.1 Equity Offerings 66
9.1.1 Peptron to Raise USD87.5 Million in Public Offering of Shares 66
9.2 Merger 67
9.2.1 Genexine Merges with EPD Biotherapeutics 67
9.3 Partnerships 69
9.3.1 Inventage Lab Enters into Co-Development Agreement with Boehringer Ingelheim 69
9.4 Venture Financing 70
9.4.1 Dreampack Secures Funds in Venture Financing 70
10 Recent Developments 71
10.1 Legal And Regulatory 71
10.1.1 Dec 04, 2024: Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court 71
10.2 Other Significant Developments 71
10.2.1 Nov 13, 2024: Celltrion Pharmaceuticals Achieves
128.1 Billion Won in Sales in Q3 71
10.2.2 Aug 14, 2024: Celltrion Pharmaceuticals Achieves
117.1 Billion Won in Sales in Q2 72
10.2.3 May 16, 2024: Celltrion Pharmaceuticals Achieves 97 Billion Won in Sales in Q1 72
10.3 Product News 73
10.3.1 Oct 09, 2024: Daewoong Pharmaceutical Unveils 'Innovative Drug Delivery Technologies' in Milan From World's First Microneedle Therapy to Once-a-Month Obesity Treatment 73
10.3.2 Sep 10, 2024: “Dermatologic Surgery” Journal Publishes Special Issue on Neuromodulators 74
11 Appendix 76
11.1 Research Methodology 77
11.1.1 Coverage 77
11.1.2 Secondary Research 77
11.1.3 Primary Research 78
11.1.4 Market Modeling and Forecasting 79
11.1.5 Company Share Analysis 80
11.1.6 Distribution Share Analysis 80
11.1.7 Benchmarking 81
11.2 GlobalData Consulting 81
11.3 Contact Us 81
11.4 Disclaimer 82